Institutes outside Greece
Wechselwirkungen zwischen kapillar-morphogenese gen 2 und androgenen bei der genese und progression des prostatakarzinoms
Abstract
dc:descriptionCMG2 has been identified as a gene that is upregulated during angiogenesis. It has since been shown that CMG2 plays an important role in endothelial cell proliferation and in the formation of capillary-like networks in vitro. CMG2 was identified in vivo as a regulator of membrane-type 1 metalloproteinase, which is a key mediator of type 1 collagen degradation and an important promoter of angiogenesis and tumor growth. In 2009, increased expression of the CMG2 isoform 322 was detected in prostate cancer tissue. Furthermore, it has been shown that CMG2 is induced by testosterone in the prostate cancer cell line HPr-1AR. The aim of this study is to investigate in more detail the regulation of CMG2 mRNA by androgens in prostate cancer cells, as well as the association of serum CMG2 with the genesis and progression of prostate cancer. CMG2 mRNA expression in prostate cancer cells under the influence of androgens was examined in vitro. The prostate cancer cell lines DU145 and LNCaP were treated with 2 or 10 nM testosterone or dihydrotestosterone (DHT) for 24 hours, and CMG2 mRNA expression was measured by qPCR. The in vitro treatment of LNCaP cells (hormone-sensitive) with 10 nM DHT for 24 hours resulted in a 2.11-fold increase in CMG2 mRNA expression compared to untreated LNCaP cells (p=0.01; Student’s t-test). Treatment of LNCaP cells with 2 and 10 nM testosterone and with 2 nM DHT did not significantly affect CMG2 mRNA expression, and the same treatment of DU145 cells (hormone-insensitive) also did not result in any statistically significant induction of CMG2 mRNA. Furthermore, secreted CMG2 protein (CMG2-322) was measured in the serum of prostate cancer patients (n=210) at various tumor stages and under different treatment regimens. The results were compared with the levels of CMG2-322 in the serum of “healthy” men (control group, n=133). The measurements were performed using a commercial ELISA (antibodies.online, Aachen). The study received approval from the Ethics Committee of Martin Luther University Halle-Wittenberg. Overall, no direct correlation was found between serum CMG2 levels and the presence of prostate cancer. However, a statistically significant positive correlation was demonstrated between the metastasis and progression of prostate cancer and elevated serum CMG2 protein levels (p=0.009; Mann-Whitney U test).
Degree
thesis:*- Grantor dc:publisher
- Institutes outside Greece
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Marcou, Marios
- Μάρκου, Μάριος
Subjects
dc:subject × 9Rights
- Language dc:language
- ger
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/62882